| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |